Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Comparative analysis of the tumor immune-microenvironment of primary and brain metastases of non-small-cell lung cancer reveals organ-specific and EGFR mutation-dependent unique immune landscape
Seung Geun Song, Sehui Kim, Jaemoon Koh, et al.
Cancer Immunology Immunotherapy (2021) Vol. 70, Iss. 7, pp. 2035-2048
Closed Access | Times Cited: 113

Showing 1-25 of 113 citing articles:

Classification of Tumor Immune Microenvironment According to Programmed Death-Ligand 1 Expression and Immune Infiltration Predicts Response to Immunotherapy Plus Chemotherapy in Advanced Patients With NSCLC
Dongchen Sun, Jiaqing Liu, Huaqiang Zhou, et al.
Journal of Thoracic Oncology (2023) Vol. 18, Iss. 7, pp. 869-881
Open Access | Times Cited: 43
The Use of Iron Oxide Nanoparticles to Reprogram Macrophage Responses and the Immunological Tumor Microenvironment
Vladimir Mulens‐Arias, José M. Rojas, Domingo F. Barber
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 59
Tumor Immune Microenvironment and Immunotherapy in Brain Metastasis From Non-Small Cell Lung Cancer
Yu-Chang Wang, Rui Chen, Yue Wa, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 39
Progress in personalized immunotherapy for patients with brain metastasis
Lalit R. Patel, Nikola Kolundžić, Malak Abedalthagafi
npj Precision Oncology (2025) Vol. 9, Iss. 1
Open Access | Times Cited: 1
Exploring the Molecular Tumor Microenvironment and Translational Biomarkers in Brain Metastases of Non-Small-Cell Lung Cancer
Jiexi Wen, Jie Zeng Yu, Catherine Liu, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 2044-2044
Open Access | Times Cited: 7
FGFR1 overexpression in non-small cell lung cancer is mediated by genetic and epigenetic mechanisms and is a determinant of FGFR1 inhibitor response
Olga Bogatyrova, Johanna Sofia Margareta Mattsson, Edith Ross, et al.
European Journal of Cancer (2021) Vol. 151, pp. 136-149
Open Access | Times Cited: 38
Neuroinflammatory Gene Expression Analysis Reveals Pathways of Interest as Potential Targets to Improve the Recording Performance of Intracortical Microelectrodes
Sydney Song, Brianna Regan, Evon S. Ereifej, et al.
Cells (2022) Vol. 11, Iss. 15, pp. 2348-2348
Open Access | Times Cited: 22
Harnessing immunotherapy for brain metastases: insights into tumor–brain microenvironment interactions and emerging treatment modalities
Dairan Zhou, Zhenyu Gong, Dejun Wu, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 13
Risk factors for brain metastasis in lung cancer: an umbrella review of systematic reviews and meta-analyses
Xinliang Wan, Handan Mo, Jixin Chen, et al.
BMJ Open (2025) Vol. 15, Iss. 1, pp. e087181-e087181
Open Access
Targeting adenosine enhances immunotherapy in MSS colorectal cancer with EGFRvIII mutation
Fei Sun, Fangzhen Yao, Chunting Zeng, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 2, pp. e010126-e010126
Open Access
The coming of age of liquid biopsy in neuro-oncology
Giulia Berzero, Valentina Pieri, Pietro Mortini, et al.
Brain (2023) Vol. 146, Iss. 10, pp. 4015-4024
Open Access | Times Cited: 12
Radiomics for the non-invasive prediction of PD-L1 expression in patients with brain metastases secondary to non-small cell lung cancer
Anna-Katharina Meißner, Robin Gutsche, Norbert Galldiks, et al.
Journal of Neuro-Oncology (2023) Vol. 163, Iss. 3, pp. 597-605
Open Access | Times Cited: 11
Utilizing network pharmacology and experimental validation to explore the mechanisms of the Qijiafuzheng formula promoting CD8+ T-cell infiltration in the microenvironment of lung adenocarcinoma through STAT1/CXCL10
Tao Yang, Jian Chen, Zhonghui He, et al.
Journal of Asian Natural Products Research (2025), pp. 1-19
Closed Access
Chlorin e6-induced photodynamic effect facilitates immunogenic cell death of lung cancer as a result of oxidative endoplasmic reticulum stress and DNA damage
Tingting Yu, Jun Hu, Qi‐Rui Li, et al.
International Immunopharmacology (2023) Vol. 115, pp. 109661-109661
Closed Access | Times Cited: 10
Outcome differences between PD-1/PD-L1 inhibitors-based monotherapy and combination treatments in NSCLC with brain metastases
Hao‐Wei Wang, Fangfang Liu, Xiaoxia Chen, et al.
Experimental Hematology and Oncology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 9
The Immune Landscape in Brain Metastasis
Luca D Schreurs, Alexander F. vom Stein, Stephanie T. Jünger, et al.
Neuro-Oncology (2024) Vol. 27, Iss. 1, pp. 50-62
Open Access | Times Cited: 3
Immune Checkpoint Inhibitors for Brain Metastases in Non-Small-Cell Lung Cancer: From Rationale to Clinical Application
Gang Xiao, Zhiyuan Liu, Xuan Gao, et al.
Immunotherapy (2021) Vol. 13, Iss. 12, pp. 1031-1051
Open Access | Times Cited: 20
The accuracy of absolute differential abundance analysis from relative count data
Kimberly Roche, Sayan Mukherjee
PLoS Computational Biology (2022) Vol. 18, Iss. 7, pp. e1010284-e1010284
Open Access | Times Cited: 14
Molecular Mechanisms Driving the Formation of Brain Metastases
Bethany K. Campbell, Zijie Gao, Niall M. Corcoran, et al.
Cancers (2022) Vol. 14, Iss. 19, pp. 4963-4963
Open Access | Times Cited: 14
Evolution of the Tumor Microenvironment toward Immune-Suppressive Seclusion during Brain Metastasis of Breast Cancer: Implications for Targeted Therapy
Myung‐Giun Noh, Sung Sun Kim, Yeong Jin Kim, et al.
Cancers (2021) Vol. 13, Iss. 19, pp. 4895-4895
Open Access | Times Cited: 18
Proteomics-based Model for Predicting the Risk of Brain Metastasis in Patients with Resected Lung Adenocarcinoma carrying the EGFR Mutation
Qiuhua Deng, Fengnan Wang, Lei Song, et al.
International Journal of Medical Sciences (2024) Vol. 21, Iss. 4, pp. 765-774
Open Access | Times Cited: 2
Screening and evaluation of the role of immune genes of brain metastasis in lung adenocarcinoma progression based on the TCGA and GEO databases
Cheng Chen, Qiang Guo, Yang Tang, et al.
Journal of Thoracic Disease (2021) Vol. 13, Iss. 8, pp. 5016-5034
Open Access | Times Cited: 16
Osimertinib combined with bevacizumab as the first‐line treatment in non‐small cell lung cancer patients with brain metastasis harboring epidermal growth factor receptor mutations
Ling Zhang, Yunhong You, Xueli Liu, et al.
Thoracic Cancer (2023) Vol. 14, Iss. 15, pp. 1355-1361
Open Access | Times Cited: 6
An HLA-G/SPAG9/STAT3 axis promotes brain metastases
Blessing Bassey‐Archibong, Chirayu Chokshi, Nikoo Aghaei, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 8
Open Access | Times Cited: 5
The effect of organ-specific tumor microenvironments on response patterns to immunotherapy
Jordan W. Conway, Jorja Braden, James S. Wilmott, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top